Process to prepare treprostinil, the active ingredient in remodulin®
US-2015376106-A1 · Dec 31, 2015 · US
US2016009635A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016009635-A1 |
| Application number | US-201514796069-A |
| Country | US |
| Kind code | A1 |
| Filing date | Jul 10, 2015 |
| Priority date | Jul 10, 2014 |
| Publication date | Jan 14, 2016 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention provides methods for preparing substituted phenylalkanes. In particular, the processes comprise reacting a phenyl boronic compound with an α-β unsaturated carbonyl-containing compound via an asymmetric 1,4-addition reaction. The processes may be useful in the synthesis of tapentadol.
Opening claim text (preview).
What is claimed is: 1 . A process for preparing a compound of Formula (VI), the process comprising: a) contacting a compound of Formula (I) with a compound of Formula (VIII) in the presence of a transition metal catalyst and a chiral ligand to form a compound of Formula (IX); b) contacting the compound of Formula (IX) with a secondary amine having Formula (X) to form a compound of Formula (V); and c) contacting the compound of Formula (V) with an O-dealkylating agent to form the compound of Formula (VI), wherein: R is alkyl or alkyl substituted with other than aryl; R 1 is hydrogen, alkyl, or substituted alkyl; R 2 is hydrocarbyl or substituted hydrocarbyl; R 3 , R 4 , R 5 , and R 7 are independently hydrogen, OR 20 , NR 20 R 21 , SR 20 R 21 , halo, hydrocarbyl, or substituted hydrocarbyl; R 8 is —O—(CR 13 R 14 ) n —O—, or trihalo; R 10 and R 11 are independently hydrocarbyl, substituted hydrocarbyl, or R 10 and R 11 together may form a ring or ring system selected from carbocyclic, heterocyclic, aryl, heteroaryl, or combinations thereof; R 12 is hydrocarbyl or substituted hydrocarbyl; R 13 and R 14 are independently hydrogen, hydrocarbyl, substituted hydrocarbyl, or boron containing moiety; R 20 and R 21 are independently hydrogen, hydrocarbyl, or substituted hydrocarbyl; and n is an integer of 1 or greater. 2 . The process of claim 1 , wherein R 1 is hydrogen, alkyl, or substituted alkyl; R 2 is alkyl or substituted alkyl; R 3 , R 4 , R 5 , and R 7 are independently hydrogen, alkyl, substituted alkyl, hydroxyl, alkoxy, substituted alkoxy, aryl, substituted aryl, alkylaryl, or substituted alkylaryl; R 10 and R 11 are independently alkyl or substituted alkyl; and R 13 and R 14 are independently hydrogen, alkyl, aryl, or alkylaryl. 3 . The process of claim 2 , wherein R 1 is C 1 -C 10 alkyl; R 2 is C 1 -C 10 alkyl; R 3 , R 4 , R 5 , and R 7 are hydrogen; and R 10 , R 11 and R 12 are C 1 -C 10 alkyl. 4 . The process of claim 1 , wherein R is methyl; R 1 is hydrogen; R 2 is ethyl; each of R 3 , R 4 , R 5 , and R 7 is hydrogen; and R 10 , R 11 , and R 12 are methyl. 5 . The process of claim 1 , wherein the compound of Formula (I), the compound of Formula (VIII), and the transition metal catalyst are present at a molar ratio of about 1:0.5:0.001 to about 1:2.0:0.05; and step (a) is conducted at a temperature from about −10° C. to about 80° C. 6 . The process of claim 5 , wherein the transition metal catalyst is a transition metal complex chosen from a rhodium complex, a palladium complex, or a ruthenium complex; the chiral ligand is a bicyclic chiral diene; and the transition metal catalyst and the chiral ligand are present at a weight ratio of about 1:0.1 to about 1:10. 7 . The process of claim 6 , wherein the compound of Formula (IX) is obtained with a diastereomeric excess of at least about 60%. 8 . The process of claim 6 , wherein step (a) further comprises contact with an amine, the amine being secondary, tertiary, chiral, or achiral. 9 . The process of claim 8 , wherein the compound of Formula (I) and the amine are present at a molar ratio of about 1:0.01 to about 1:1.0. 10 . The process of claim 9 , further comprising contact with a proton acceptor. 11 . The process of claim 10 , wherein the compound of Formula (I) and the proton acceptor are present at a molar ratio of about 1:0.01 to about 1:2. 12 . The process of claim 11 , wherein the compound of Formula (IX) is obtained with a diastereomeric excess of at least about 70%. 13 . The process of claim 1 , wherein the compound of Formula (IX) and the compound of Formula (X) are present at a molar ratio of about 1:0.5 to about 1:60; and step (b) is conducted at a temperature of about 0° C. to about 80° C. 14 . The process of claim 13 , further comprising contact with a reducing agent. 15 . The process of claim 14 , wherein the compound of Formula (IX) and the reducing agent are present at a weight ratio of about 1:0.3 to about 1:5. 16 . The process of claim 1 , wherein the O-dealkylating agent and the compound of Formula (V) are present at weight ratio of about 1:1 to about 400:1; and step (c) is conducted at a temperature of about 50° C. to about 200° C. 17 . The process of claim 1 , wherein the compound of Formula (I) is m-methoxyphenylboronic acid, 3-methoxyphenyl trifluoroborate, 3-methoxyphenylboronic acid pinacol ester, 3-methoxyphenylboronic ester, or is derived from 3-methoxyphenylboroxine; the compound of Formula (VIII) is trans-2-methyl-2-pentenal; the transition metal catalyst is [RhCl(C 2 H 4 ) 2 ] 2 ; the chiral ligand is (1S,4S)-2,5-diphenylbicyclo[2,2,2]octa-2,5-diene; the compound of Formula (X) is dimethylamine; the O-dealkylating agent is a hydrogen halide; and the compound of Formula (VI) is 3-[(1R,2R)-3-(dimethyamino)-1-ethyl-2-methylpropyl]phenol. 18 . The process of claim 17 , wherein step (a) further comprises contact with an amine and, optionally, a proton acceptor; the amine being 4-methyl morpholine. 19 . The process of claim 18 , wherein the compound of Formula (I), the compound of Formula (VII), the transition metal catalyst, the chiral ligand, the amine, and the optional proton acceptor are present at a molar ratio of 1:1.15:0.007:0.4:0.2; step (a) is conducted at a temperature of about 23° C. and under nitrogen; the compound of Formula (IX) and the compound of Formula (X) are present at a molar ratio of about 1:1; step (b) is conducted in the presence of a reducing agent, at a temperate of about 23° C., and under nitrogen; the O-dealkylating agent and the compound of Formula (V) are present at a weight ratio of about 26:1; and step (c) is conducted at a temperature of about 110° C. and under nitrogen. 20 . The process of claim 19 , wherein the compound of Formula (VI) has a yield of at least about 30%.
by increase in the number of carbon atoms · CPC title
by addition to carbon-to-carbon double or triple bonds · CPC title
Optical isomers · CPC title
by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups · CPC title
by hydrogenation of carbon-to-carbon double or triple bonds · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.